β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy

Gunter Johannes Sturm, Sereina Annik Herzog, Werner Aberer, Teresa Alfaya Arias, Darío Antolín-Amérigo, Patrizia Bonadonna, Elisa Boni, Andrzej Bożek, Marta Chełmińska, Barbara Ernst, Nina Frelih, Radoslaw Gawlik, Asli Gelincik, Thomas Hawranek, Wolfram Hoetzenecker, Aránzazu Jiménez Blanco, Karolina Kita, Reşat Kendirlinan, Mitja Košnik, Karin LaipoldRoland Lang, Francesco Marchi, Marina Mauro, Marita Nittner-Marszalska, Iwona Poziomkowska-Gęsicka, Valerio Pravettoni, Donatella Preziosi, Oliviero Quercia, Norbert Reider, Marta Rosiek-Biegus, Berta Ruiz-Leon, Christoph Schrautzer, Pilar Serrano, Aytül Sin, Betül Ayşe Sin, Johanna Stoevesandt, Axel Trautmann, Martina Vachová, Lisa Arzt-Gradwohl

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences